Explore Global Companies & Account Intelligence

Immuno Diagnostic is a Distributor of Diagnostic and Research reagents and instruments in Finland and surrounding countries. We represent leading suppliers in the fields of molecular diagnostics, histopathology, imaging as well as life science research reagents and food diagnostics. Being present in the Nordic markets since 1983, we can provide our customers with a range of high quality products and excellent customer and technical service. We represent well established suppliers providing our customers a reliable source for research tools with modern technologies. Our quality management system is ISO9001:2015 certified. Immuno Diagnostic Oy is a part of AddLife AB.

Immuno is a federally licensed medical laboratory. Immuno provides products and services to physicians with a focus on helping physicians by providing real relief for their patients with chronic unsolved conditions. 88% of consumers rate themselves from "good"​ to "excellent"​ in their health, yet 56% have been diagnosed with a one or more chronic conditions. If there was one food that was causing your chronic condition; your headaches; your stomach pains; your skin issues; would you want to know what that food is? That is what we do at Immuno, we precisely pinpoint the foods that are toxic to your body and guide you to better health.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. ImmunoCellular’s pipeline also includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a dendritic cell immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient’s hematopoietic stem cells to generate antigen-specific cancer-killing T-cells.

Saving Critical Time and Resources Today, to Bring New Medicine to Patients Tomorrow! - Protocol Design - Lab Guidance - Data Analysis - Site Monitoring - Tech Transfer

Comprehensive enterprise dossier available in global intelligence registry.

Immunordic increases accessibility of unique nanobodies for targeted therapeutics, diagnostics and research tools. Our platform is based on the largest and most cost-efficient synthetic nanobody library on the market thus allowing Immunordic to reduce prices and turnaround time compared to competing options on the market.

Immunoshop is a leading Indian diagnostic company with a 20-year legacy of excellence in the in-vitro diagnostics (IVD) industry. We proudly represent some of the world’s most trusted brands, including Aesku Germany, Diasource Belgium, Diesse Italy, Wantai China, Mindray, and SNIBE, bringing cutting-edge solutions to laboratories across India. Our product portfolio is one of the most comprehensive in the market, featuring ELISA, Blots, IFA, CLIA, HPLC, and POCT, Lab automation, hematology, and veterinary diagnostics. With a state-of-the-art manufacturing facility, we have added a range of rapid tests, ELISA kits, and veterinary diagnostics, making us your trusted partner for innovation and reliability. Supported by a large, robust team of sales professionals and service engineers across India and a network of 100+ active sub-distributors, Immunoshop ensures nationwide reach and exceptional after-sales support. Our mission is to provide seamless diagnostic solutions that empower labs across India to deliver accurate and timely results. Join us as we continue to shape the future of diagnostics in India with an unwavering commitment to quality, innovation, and customer satisfaction

Immunotherapy Foundation (IF) was established in 2015 to support cutting-edge immunotherapy research at Moores Cancer Center at the University of California, San Diego (UCSD) and the La Jolla Institute for Allergy and Immunology (LIAI). This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs. IFs initial mission is to find an effective treatment - and ultimately a cure - for HPV-related cancers. IF is recognized by the IRS as a public nonprofit organization under section 501(c)(3) of the Internal Revenue Code.

ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect. The company is developing a bio-selected RNA virus to induce tumour inflammation and achieve immune cell infiltration via the RIG-I pathway. The targets for this approach are Ovarian, Head & Neck and those indications which present with liver metastases such as Colorectal, Hepatocellular carcinoma and Pancreatic cancer. The approach includes combination therapy with Immune Checkpoint Inhibitors and CAR-T agents using bio-selected RNA virus. The company founders, Malcolm McColl and Prof. Darren Shafren, were Managing Director and CSO of Viralytics, an ASX listed oncolytic virus company acquired in June 2018 by Merck and Co. Inc. for A$502 million. The ImmVirX team includes key management and researchers from Viralytics and is based at the former Viralytics laboratory facilities in Newcastle Australia.

Conseil en Organisation et Systèmes dInformation - Conseil en organisation / méthodologie - Éditeur GED - Intégrateur de solution CRM en mode SaaS - distributeur de plateforme conversationnelle Niveaux d'intervention : - Conseil et Assistance à Maîtrise d'Ouvrage : Définition de stratégies, études d'opportunité, méthodologie, conception de schémas directeurs, audits (fonctionnels, organisationnels et techniques), définition d'architecture ... - Maîtrise d'Oeuvre : Conduite ou coordination de projets, conduite du changement, rédaction de cahiers des charges, rédaction de spécifications fonctionnelles et techniques, validation de solutions, choix et pilotage de fournisseurs, suivi qualité, développements ...

At IMnS Associates, we pride ourselves on being an innovative consultancy firm that delivers exceptional financial and business services. Our team of experts is dedicated to helping businesses with finance and management, ensuring they are poised for success in today's competitive market. Our Expertise: ✔Private Equity Research & Strategic Planning: Crafting investor-ready business plans and developing sales and marketing strategies. Expertise in SEO, SMM, and SMO strategy planning. ✔Business Valuations & Feasibility Studies: Offering business valuations, investment appraisals, and portfolio management services. ✔Financial Modeling, Analysis, and Reporting: Insights and analyses for business growth and efficiency. ✔Tax Consultancy: Return filing and efficient refund processing, ensuring tax compliance. ✔Audit & Risk Management: Fraud examinations, forensic, internal, statutory, and IT audits for risk mitigation and compliance. ✔Project Management & VBA Excel Dashboards: World-class project management with insightful VBA Excel Dashboards. ✔Financial Projections & Analysis: Creating financial statements, projections, ratio analysis, and KPI assessments. ✔Financial Reporting & Accounting Advisory: Expertise in IFRS & GAAP for standard-compliant financial practices. ✔Book-keeping Services: Proficient in Xero, QuickBooks, Waveapps, FreshBooks, Sage, Simply Accounting, Peachtree, etc. ✔Advanced Excel Modelling: Handling complex Excel modeling assignments with customized solutions. Connect with Us: Join our journey of redefining business excellence. Your success is our commitment. Partner with us for innovative, integrity-driven insights.

IMO - Istituto di Medicina Omeopatica S.p.A è unindustria farmaceutica impegnata dal 1947 nella produzione e distribuzione di Medicinali Omeopatici. IMO nasce su iniziativa di un gruppo di medici, con lobiettivo di favorire lo sviluppo e la divulgazione della Medicina Omeopatica sull'esempio dei successi già registrati in Paesi stranieri, come Francia, Germania e Inghilterra. Oggi, il know-how acquisito nello sviluppo delle tecniche produttive, controllo qualità e soluzioni terapeutiche, posiziona IMO come un assoluto punto di riferimento nellambito di Omeopatia e Medicina Integrata, offrendo a medici, farmacisti e pazienti italiani uno tra i più completi repertori terapeutici Omeopatici e Nutraceutici. Limpegno di IMO si articola su tre piani sinergici: - Formazione scientifica, ricerca & sviluppo, ricerca clinica - Produzione e commercializzazione secondo i più rigidi standard qualitativi farmaceutici (GMP) ed UNI EN ISO (9001 - 13485) - Distribuzione commerciale con tre diverse reti dedicate sia allinformazione medica, sia al canale farmacia Negli ultimi anni IMO ha allargato la propria offerta terapeutica anche alla Medicina Funzionale e alla Nutrizione specializzandosi nei settori degli oligoelementi e degli integratori alimentari. Numerose sono le iniziative di successo dedicate a medici e farmacisti per la divulgazione scientifica della Medicina Omeopatica, tra cui: - Redazione della rivista Omeopatia Oggi - Promozione di incontri scientifici ed eventi formativi - Organizzazione di corsi di aggiornamento scientifico accreditati ECM - Collaborazione con prestigiose Università, Associazioni e Società Scientifiche - Ricerca clinica con trial clinici e studi osservazionali IMO è attiva anche nel sociale: - Aderisce al programma Corporate Golden Donor a sostegno del FAI - Fondo Ambiente Italiano - Promuove lattività sportiva sponsorizzando la ASD Robur Basket Saronno IMO è associata a: Omeoimprese, Echamp e Assolombarda.